THThe Hindu·1hHealth
score-0.10
Why India rejected a patent application for shorter drug-resistant TB treatment | Explained
Original
Why India rejected a patent application for shorter drug-resistant TB treatment | Explained
“Highlights the negative regulatory barrier while noting the potential for future cost reduction.”